About Avicenna AI
Avicenna AI is a Healthcare company based in La Ciotat (France) founded in 2018 by Cyril Di Grandi and Peter Chang. Provider of AI-based medical imaging software for radiologists. Avicenna AI has raised $7.5 million across 1 funding round from investors including Exotrail, Innovacom and CEMAG Invest. Avicenna AI offers products and services including CINA-ICH, CINA-LVO, CINA-ASPECTS, CINA-PE, and CINA-AD. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations.
Company details
Avicenna was founded in 2018 in La Ciotat, France, within the healthcare technology sector. Medical imaging software is offered to support radiologists, with operations centered on CT-scan analysis. Artificial intelligence algorithms are developed to identify and prioritize cases, enabling detection of critical conditions. The company focuses on tools that integrate into radiology workflows for improved efficiency in diagnostic processes.
- Headquarters La Ciotat, France
- Founders Cyril Di Grandi, Peter Chang
- SectorsHealthcare
- Website avicenna.ai
- Social LinkedIn X Facebook YouTube
- Total Equity Funding$7.5M (USD)
in 1 rounds
- Latest Funding Round$7.5M (USD), Series A
Feb 2023
- InvestorsExotrail
& 2 more
Products & Services of Avicenna AI
Avicenna AI offers a comprehensive portfolio of products and services, including CINA-ICH, CINA-LVO, CINA-ASPECTS, CINA-PE, and CINA-AD.
Detects intracranial hemorrhage on non-contrast CT scans.
Identifies large vessel occlusion in ischemic strokes.
Assesses acute ischemic stroke via scoring and heat maps.
Automatically detects pulmonary embolism on chest CT.
Identifies aortic dissection for urgent intervention.
Apps and channels of Avicenna AI
its YouTube channel Avicenna AI has 37 subscribers and 24 videos.
Videos from Avicenna AI
The most watched videos on Avicenna AI's YouTube channel, Avicenna AI (37 subscribers). Click a video to play it here.
More on Avicenna AI.
Funding Insights of Avicenna AI
Avicenna AI has successfully raised a total of $7.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.5 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.5M
- Total Rounds 1
- Last Round Series A — $7.5M
- First Round $7.5M
(Feb 2023)
- Investors Count 3
All 1 funding rounds of Avicenna AI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2023 | $7.5M | Series A | – | Innovacom, CEMAG Invest |
3 investors in total: 3 institutional.
Investors in Avicenna AI
Avicenna AI has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Exotrail, Innovacom and CEMAG Invest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are directed toward early-stage technology-led companies by Innovacom. | innovacom.com | Paris, France | ||
Mobility solutions for small satellites are developed and provided. | 2016 | exotrail.com | Palaiseau, France |
Investor details for Avicenna AI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Avicenna AI
25 people are tracked at Avicenna AI (4 in leadership, 21 in team).
| Name | Role | Group |
|---|---|---|
Cyril Di Grandi | Co-Founder | Leadership |
Peter Chang | Co-Founder | Leadership |
Martijn Jonkers | VP Sales EMEA | Leadership |
Sarah Quenet | Director Of Product | Leadership |
Fanny Monéger | Clinical & Regulatory Affairs Associate | Team |
Martina Cotena | Clinical Studies Specialist Engineer | Team |
Shannon Seghier | Quality Engineer / Back-up PRRC & Vigilance | Team |
Alexandre Chery | Spécialiste Clinique | Team |
Angela Ayobi | Clinical & Scientific Research Engineer | Team |
Yasmina Chaibi | Clinical Affaires & Validation Manager | Team |
Angelo Franciosini | Design Development & Qualification Engineer | Team |
Charlotte Castineira | Product Engineer | Team |
Marlène Scudeler | Clinical Specialist | Team |
Stéphane Berger | Regulatory & Quality Manager | Team |
Stéphanie Bellavia | Marketing & Communication Manager | Team |
Olivier Fuseri | Business Development Manager | Team |
Cécile Madaras | Regulatory & Clinical Affairs Engineer | Team |
Sylvain Fogola | Project Manager | Team |
Daniel Chow | Radiologist | Team |
Vladimir Laletin | Scientific And Clinical Research Engineer | Team |
5 more people are available in the full profile.
Complete people profiles for Avicenna AI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Avicenna AI
2 dated milestones of Avicenna AI across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Avicenna AI is founded.
- Funding First funding round of $7.5M.
Web traffic of Avicenna AI
The website of Avicenna AI (avicenna.ai) receives about 3.3K visits a month.
- Monthly visits3.3K
▼ 19.2% vs previous month
Websites whose visitors overlap most with Avicenna AI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ctread.com | ctread.com | 100% | #324,738 | – | |
frenchhealthcare.fr | frenchhealthcare.fr | 100% | #4,914,987 | – | |
annalise.ai | annalise.ai | 88% | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Avicenna Ai
Complete news archive for Avicenna AI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avicenna AI
Avicenna AI was founded in 2018 and raised its 1st funding round 5 years after it was founded.
Avicenna AI is headquartered in La Ciotat, France. It is registered at La Ciotat, Provence-alpes-cote D'azur, France.
Avicenna AI is a funded company, having raised a total of $7.5M across 1 funding round to date. The company's 1st funding round was a Series A of $7.5M, raised on Feb 2023.
Avicenna was founded in 2018 in La Ciotat, France, within the healthcare technology sector. Medical imaging software is offered to support radiologists, with operations centered on CT-scan analysis. Artificial intelligence algorithms are developed to identify and prioritize cases, enabling detection of critical conditions. The company focuses on tools that integrate into radiology workflows for improved efficiency in diagnostic processes.
Avicenna AI offers CINA-ICH, CINA-LVO, CINA-ASPECTS, CINA-PE, and CINA-AD.